PURETECH HEALTH PLC - Profile & Financials

CompanyTrack

Accounts Submitted 19 May 2025 Next due 30 Jun 2026 14 days remaining

Confirmation Submitted 14 May 2025 Next due 22 May 2026 25 days overdue

Net assets £306M £102M 2025 year on year

Total assets £535M £68M 2025 year on year

Total Liabilities £229M £34M 2025 year on year

Charges None No charges registered

Contact & Details

Contact

Registered Address

C/O Tmf Group, 13th Floor One Angel Court London EC2R 7HJ United Kingdom

Telephone

0800 000 0000

Website

www.example.com

Full company profile for PURETECH HEALTH PLC (09582467), an active life sciences and medical technology company based in London, United Kingdom. Incorporated 8 May 2015. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Period 1 Jan → 31 Dec 2025

Type group

Next accounts 31 Dec 2025

Due by 30 Jun 2026 14 days remaining

Balance Sheet & P&L (2015–2025)

Cash in Bank

£278.89M

Decreased by £90.05M (-24%)

Net Assets

£305.68M

Decreased by £102.26M (-25%)

Total Liabilities

£229.03M

Increased by £34.33M (+18%)

Turnover

£5.99M

Decreased by £151.61M (-96%)

Employees

N/A

Decreased by 80 (-100%)

Debt Ratio

43%

Increased by 11 (+34%)

Financial History

Revenue, profit, EBITDA and key financial figures

	2025 31 Dec Year End	2024 31 Dec Year End
P&L
Revenue	£142.3M	£128.7M
Gross Profit	£48.2M	£43.1M
Operating Profit	£22.4M	£19.8M
Net Profit	£18.1M	£15.9M
EBITDA	£31.5M	£28.2M
Assets
Cash	£24.7M	£21.3M
Total Assets	£89.4M	£82.1M
Liabilities
Total Liabilities	£45.2M	£41.8M
Key Metrics
Employees	1,247	1,156

Latest Revenue

£142.3M

Latest EBITDA

£31.5M

Cash Position

£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Share Capital

Share allotments and capital structure

65 Allotments 129,778,027 Shares £124.90m Total

Date From	Share Class	Shares Allotted	Amount Raised	Price/Share
13 Jan 2023	ORDINARY	67,771	£677.71	£0.01
12 Jan 2023	ORDINARY	99,050	£990.5	£0.01
11 Jan 2023	ORDINARY	85,362	£853.62	£0.01
10 Jan 2023	ORDINARY	54,323	£543.23	£0.01
22 Nov 2022	ORDINARY	81,111	£811.11	£0.01

Officers

1 active 2 resigned

Show resigned officers

						Status
Holcomb, Michele Ann Mc Mahon	Director	American	United States	58	23 Sept 2024	Active

Shareholders

Shareholders (19)


Invesco Asset Management	23.3%
Jupiter Asset Management Limited	5.5%

Persons with Significant Control

Persons with Significant Control (0)

No PSC information available

Group Structure

No group structure identified

Charges

No charges registered

Properties

0 total

No related properties

Documents

Company Filings

Date	Category	Description
8 May 2026	Officers	Change to director Dr. John Lamattina on 7 May 2026
8 May 2026	Officers	Change to director Dr Robert Langer on 7 May 2026
7 May 2026	Officers	Change to director Michele Holcomb on 7 May 2026
2 Feb 2026	Officers	Termination of Raju Kucherlapati as director on 8 Jul 2025
2 Feb 2026	Officers	Appointment of Robert William Henry Lyne as director on 18 Dec 2025

8 May 2026 Officers

Change to director Dr. John Lamattina on 7 May 2026

8 May 2026 Officers

Change to director Dr Robert Langer on 7 May 2026

7 May 2026 Officers

Change to director Michele Holcomb on 7 May 2026

2 Feb 2026 Officers

Termination of Raju Kucherlapati as director on 8 Jul 2025

2 Feb 2026 Officers

Appointment of Robert William Henry Lyne as director on 18 Dec 2025

Recent Activity

Latest Activity